Navigation Links
Poor in Medical Technology

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

... with actionable information for patients who are poor responders to clopidogrel (Plavix(R)). The ... whether tailored antiplatelet therapy for poor responders, identified based on the results of ... increased frequency is the question of whether poor response to antiplatelet therapy, based on a ...

American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought

... Patients in both groups had similar numbers of poor asthma control episodes, and there were no ... acid reflux does not play a significant role in poor asthma control. Talk with your doctor before ... The primary outcome was the rate of episodes of poor asthma control (EPACs) based on asthma diaries. ...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

... of genetic abnormalities that together predicted poor outcome." The most significant association ... who were treated in the COG study that had a very poor prognosis. The prognostic significance of these ... to alter patients' therapy if they have a very poor response to treatment," said James Downing, M.D., ...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

... May Lead to Overall Survival in Patients with poor Prognostic Factors SAN FRANCISCO, Dec. 9 ... lymphocytic leukemia (CLL) patients who have poor prognostic indicators. These findings were ... 17 (17p deletion), which may indicate a poor prognosis including significantly inferior ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... in all patient sub-groups, including those with poor prognostic characteristics, such as advanced age, poor risk cytogenetics and renal impairment. These ... A subset analysis of VcMP treated patients with poor prognostic features, including age >75 years ...

Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)

... of patients in the trial had intermediate or poor risk cytogenetics (bone marrow tests to identify abnormal chromosomes), which are associated with poor prognoses. Responses were observed across all patients including those with poor risk cytogenetics, those whose AML transformed ...

New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact

... a chronic widespread pain condition, results in poor quality of life and poses a financial burden on ... Spain, the Netherlands, Mexico and S. Korea. poor Quality of Life for Patients with Fibromyalgia ... worldwide. Fibromyalgia is usually accompanied by poor sleep, stiffness and fatigue along with other ...

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

... see impressive responses in older patients with poor prognostic cytogenetic abnormalities when treated ... disorder such as myelodysplastic syndrome (MDS), poor health performance, or intermediate or ... based on the presence of at least one of these poor prognostic factors at baseline. Patients ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... three in four patients discontinue therapy within 18 months due to either poor tolerability or incomplete efficacy. Metabolic safety, including weight ... to lack of efficacy or side effects, including metabolic side effects. poor tolerability frequently leads to treatment discontinuation even when the ...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

... and the cost of healthcare," Carrillo added. Adults Show a poor Understanding of Alzheimer's Link to Heart Health Risk Factors ... "Our data suggest that American adults have limited knowledge and a poor understanding of factors that have been demonstrated to increase risk for ...

New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform

... $800 billion on health problems that are directly linked to lifestyle and poor health habits each year--about one third of our total health care ... and lowering health care costs." "Spiraling health care costs and poor outcomes will only get worse in the absence of employer action and ...

Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

... post-chemotherapy setting are encouraging because these patients have a poor prognosis, surviving on average a year or less -- with no approved ... as hormone-refractory) prostate cancer have few treatment options and a poor prognosis. Overexpression of the androgen receptor is believed to ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... tumors in North America and Europe; moreover, patient prognosis is very poor and the treatment options are very limited. In addition, the NTI-0303 ... offer significant clinical benefit for metastatic patients, given the very poor options available now for this substantial patient population. We look ...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

... and Figures 2009). Patients with SCLC have few treatment options and a poor prognosis. Effective second-line treatment for SCLC is a major unmet ... prostate cancers. Patients with CRPC have few treatment options and a poor prognosis. About Picoplatin Picoplatin is designed to ...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

... potential predictive power. 20 percent of the 144 patients in the poor prognosis signature group achieved a pCR, whereas none of the patients ... a pCR. After a median follow-up of 25 months, 19 relapses were seen in the poor signature and none in the good signature group. These findings suggest ...

Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests

... The difference in response can range from potential fatal bleeding to poor response." "Given the varying outcomes of targeted therapies for ... of severe or fatal hemoptysis (internal bleeding in the lungs) to overall poor response. Current methods for differentiating squamous from non ...

Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology

... are seen frequently in many types of cancer and have been correlated with poor prognosis in patients with soft-tissue sarcoma, gastric, hepatocellular, ... pAkt were high-grade, advanced stage or had other features associated with poor prognosis. High pAkt is often seen in tumors that are resistant to ...

Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology

... --Complete Remissions Achieved with Voreloxin in poor Risk Frontline Elderly AML and in Combination with Cytarabine in ... agent Phase 2 trial show that voreloxin induces complete remissions in poor risk frontline elderly AML patients who are unlikely to benefit from ...

Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women

... small size on a mammogram." However, Dr. Margenthaler suspected that the poor outcomes of her young patients were related to factors beyond the lack of ... as well, in that Stage IV cancer has already spread and usually has a poor prognosis. Chemotherapy and radiation can help to control symptoms, but a ...

Body Contouring Surgery Risk Rises with Increased Body Mass Index

... important for plastic surgeons to be cognizant of potential predictors of poor outcomes and/or complications that can arise as a result," said Donald ... such as hypertension, diabetes, sleep apnea, cardiovascular disease, and poor healing, that generally accompany it." Very few studies have looked at ...

Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology

... are seen frequently in many types of cancer and have been correlated with poor prognosis in patients with soft-tissue sarcoma, gastric, hepatocellular, ... pAkt were high-grade, advanced stage or had other features associated with poor prognosis. High pAkt is often seen in tumors that are resistant to ...

Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois

... are seen frequently in many types of cancer and have been correlated with poor prognosis in patients with soft-tissue sarcoma, gastric, hepatocellular, ... pAkt were high-grade, advanced stage or had other features associated with poor prognosis. High pAkt is often seen in tumors that are resistant to ...

New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens

... growth factors (VEGF).(4) HER2 overexpression is associated with poor prognosis(5) and reduced overall survival,(6) while VEGF is linked to ... has been reported in a variety of human tumors and is associated with poor prognosis and reduced overall survival. On March 13, 2007, the United ...

St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia

... five-year, disease-free survival than those with profiles indicating a poor response. To confirm their findings, the researchers also analyzed the ... or other genetic alterations in their leukemia cells that cause such poor response. The findings broadly confirm the value of such sweeping ...

Anti-Cancer Drug CYT997 Update

... compound in specific cancer types with high unmet medical need and poor prognoses. VDAs are a new class of drugs to treat cancer and have ... Unfortunately, many patients relapse and subsequently have very poor prognoses. Experimental therapies which attack GBM blood vessels have ...

Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results

... application to new molecular entities where use may be restricted due to poor bioavailability," said Michael V. Novinski, President and Chief Executive ... of administration or the benefits of these compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. The ...

38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty

... lobbying actions like delegations to politicians on this date, shows the poor are watching how resources are allocated and want to have a say how ... debate how gender exclusion and discrimination impede development in poor countries. -- In Bangladesh just under 850,000 people stood up with the ...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

... treatment of Multiple Myeloma and Metastatic Colon Cancer. STUDY RATIONALE: Activation of the PI3K/AKT pathway has been associated with poor prognosis, or proliferation, in several pediatric tumors such as neuroblastoma, glioblastoma, rhabdomyosarcoma, and medulloblastoma. Perifosine's ...

Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'

... that cognitive function could be improved by lowering neuronal calcium concentrations. "We asked 83 healthy volunteers with self-described poor memory to consume a supplement (Prevagen(R), www.prevagen.com ) containing a protein found in jellyfish that buffers calcium by binding to it," ...

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

... "We made a significant financial investment in this pioneering effort to develop lestaurtinib for this molecularly targeted patient population with a poor prognosis and few treatment options," said Frank Baldino, Jr., Ph.D., Cephalon founder, chairman and CEO. "Patients with life-threatening diseases ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... happen in people using TNF blockers. Contact your doctor immediately if you develop symptoms such as feeling very tired, skin or eyes look yellow, poor appetite or vomiting, or pain on the right side of your stomach. Low blood counts have been seen with people using TNF blockers. If this ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... happen in people using TNF blockers. Contact your doctor immediately if you develop symptoms such as feeling very tired, skin or eyes look yellow, poor appetite or vomiting, or pain on the right side of your stomach. Low blood counts have been seen with people using TNF blockers. If this ...

Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients

... safety profile observed in this study. These results are particularly important for these patients who are in a disease stage with extremely poor prognosis and for which we lack treatment options except for patients eligible for allogenic stem cell transplantations." "The ALL interim data ...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... AVANDIA with insulin or nitrates is not recommended. AVANDIA can cause or worsen heart failure. If you have severe heart failure (very poor pumping ability of the heart) you cannot be started on AVANDIA. AVANDIA is also not recommended if you have heart failure with symptoms (such as ...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... or worsening symptoms, such as shortness of breath, swelling of ankles or feet, or sudden weight gain. Reactivation of HBV - feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain. Liver injury - jaundice (yellow skin and eyes), dark brown urine, right-sided ...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

... even at surprisingly low doses, in a heavily pre-treated patient population most of whom harbored genetic lesions known to be associated with poor response to standard therapies," said Peter Thompson, M.D., FACP, president, CEO and chairman of Trubion. "These data suggest that this novel, ...

Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients

... disease for 20 weeks (5 mos.). These specific tumor types are associated with aberrations of the PI3K pathway that commonly lead to resistance and poor prognostic outcomes. Pharmacodynamic analysis of tumor tissue confirmed inhibition of the PI3K pathway by complete absence of a downstream ...

Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy

... underpinning of heart failure is the depletion of SERCA2a enzyme in heart muscle cells, which results in abnormal intracellular calcium cycling and poor contractility," said Zsebo. "Our research shows that recombinant adeno-associated viral vectors (AAV) are ideal for restoring SERCA2a enzyme ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... suggested that patients with frequent HAE attacks, severe attacks, past laryngeal attacks, excessive loss of work or school, significant anxiety and poor quality of life could be considered for prophylaxis therapy, especially for those that fail, are intolerant, have adverse events or are not ...

MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation

... usually because of advanced age and co-morbidities, which consequently limit their treatment options. Without MR reduction, these patients have a poor quality of life, are frequently hospitalized for heart failure and have reduced survival. The High Risk Registry data showed similar 30-day ...
Other Contents
(Date:10/15/2014)... University Mainz (JGU) as a full member, ensuring ... a significant nationwide standing in the field of ... Gutenberg University Mainz as a full member of ... and international competition for the best minds and ... proud that Mainz University has been recognized as ...
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology , ... announced the availability of the VeriLook Surveillance ... 3.0 provides real-time biometric face identification using live ... surveillance cameras. The new version not only identifies ... people from objects while they are moving through ...
(Date:10/14/2014)... the planet,s leading questions is how to produce enough ... climate. The Food and Agriculture Organization of the United ... the next 40 years to feed a growing global ... necessary rise in food production. Plants—grains, cereals, fruits, ... livestock. Current research must tap into our knowledge ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... 22, 2014 The Louis ... is dedicated to distribute health information technology innovation ... worldwide announced the development of six key guiding ... when receiving healthcare. These are an expansion of ... “providing care that is respectful of and responsive ...
(Date:10/22/2014)... Grants Pass, OR (PRWEB) October 22, 2014 ... while Southern California’s fresh water supply runs dangerously low, ... climate change. Southern Oregon’s rivers, despite the lowest mountain ... fast even in late summer and early autumn.* That ... Urness, authors of the new book “Hiking Southern Oregon,” ...
(Date:10/22/2014)... Your Body’s Way , In a world where a multi-billion-dollar ... can be difficult to choose the right weight loss method. ... it the healthy way? Set aside the fads and resist ... regularly, and choose foods with the most nutritional benefits. ... exercise more and eat less. Despite the number of advertisements ...
(Date:10/22/2014)... King of Prussia, PA (PRWEB) October 22, 2014 ... Group, is recognized as an industry leader with over ... industry award winning team leader in the areas related ... In addition, Mr. Carlson is an Editorial Advisory Board ... Group Healthcare Council Educator. Blue Fin Group is ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... fertilization (IVF) are only about half as likely as white ... new research indicates, and the racial disparity persists even when ... percent of white patients became pregnant after IVF, compared to ... 4,000 IVF cycles over two years to tease out the ...
Breaking Medicine News(10 mins):Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3
Other TagsOther Tags